Partnering opportunity

H2020 FTI: An Italian engineering company search private/public hospitals and companies to define an innovative bone spinal device

Summary

An Italian engineering company skilled in mechanics systems management is developing a FTI proposal (deadline: 22-10-2019) to validate an innovative bone fusion spinal device. The device is very competitive because it can be implanted percutaneously (with a minimal invasiveness) in day-hospital also by physicians radiologist and pain therapist. Partners sought are companies and private/public hospitals to define the device and test implants on their patients.

Technical Specification or Expertise Sought

The company is looking for hospitals and private clinics experienced in spinal surgery, with interest in implanting QFusion on their patients. The collaboration of commercial health devices companies to promote and distribute QFusion and their countries is also welcome.

Partner sought

The company seeks expertise in spinal surgery from Hospitals Health Research Centres or private Clinics interested in test and implant QFusion on their patients. The collaboration of commercial health devices companies to promote and distribute QFusion in their countries is also welcome

Description

The project coordinator is an Italian engineering company skilled in precision mechanics systems. Company already develop, patented and tested on corpses an innovative bone fusion spinal device (called QFusion) in collaboration with commercial companies operating in the spinal therapy and devices market. Project goals are: device CE certification, pre-series production, validation with first users in private or public hospitals. QFusion aims at a high level of satisfaction to patients who need a spinal stabilization surgery with bone fusion. The surgical procedures using QFusion will be performed percutaneously (minimally invasive) in day-hospital with less risk and discomfort for the patients because the health recovery will be faster. The QFusion device is designed to be simple, not bulky and easy to implant on the patient spinal column. Given that are performed in EU about 200,000/year spinal stabilization surgery with bone fusion, the new device will have a high positive impact on the EU health system. The QFusion implant tests on corpses, already performed by stakeholder radiologists, showed that QFusion performances are better than other device and spinal stabilization method: the grip stability is 100% higher than the best interspinal devices now on the market. Moreover, the new device price will be 10-15% lower than the other solutions having lower performances. The QFusion patent is already registered. The CE certification to produce and introduce this new device on the market will be issued, within 2020, by authorized Agency (TUV). The applicant company will implement, during Innovation project, QFusion production process and certification as medical device (93/42/CE and 2007/47/CE, Class IIB device). Partners sought are mainly private/public Hospitals interested to test the QFusion implants on their patients, but also commercial companies to distribute the QFusion device in their countries. The partner search is limited to the following Countries: France, Germany, Spain, Austria, Switzerland and United Kingdom. Project proposal is targeted to Horizon 2020 Fast Track to Innovation Program – cut off date: 22 October 2019. The partner search deadline is 10th of September.

Advantages and innovations

QFusion will be performed percutaneously (minimally invasive) in day-hospital with less risk and discomfort for the patients because the health recovery will be more fast. QFusion can be implanted percutaneously, by radiologists and pain therapist without send their patients to orthopedic surgeon (or neurosurgeon).This hospital day procedure will allow hospitals to reduce the patient's hospitalization by 2 days with consequent savings in costs and space. Furthermore, QFusion will increase patient satisfaction by reducing health recovery time from 4 to 2 weeks. The main QFusion innovative features are: • griping stability on the vertebral column, obtained by a greater number of grapping systems; • very easy and quickly implant percutaneously; • competitive price The only fusion bone interspinous device actually available on the market is SPINEPLUS Minuteman, which however has the following disadvantage: it is larger than QFusion, involving more complications of the insertion, therefore it can be implanted with technique that can be defined semi-percutaneous (because it is a surgical intervention with a cut of more than 2 cm).

Development stage

Proposal under development

Intellectual Property Rights (IPR)

Design Rights,Patent(s) applied for but not yet granted


Register your interest

How it works

  • Tell us about yourself
  • We’ll discuss with you
  • We put the right partners in touch

EEN help you find the right partner, rather than you going it alone.

Our role is to review and collate the most suitable submissions, and then send them to the client who posted the opportunity. We consult with you, and the client, to make the process professional and easy.

These are live opportunities. Your registration of interest on the site is just like a professional approach to a business at a networking event. To stand the best chance of success, make your submission really sing. Sell why the client who posted the opportunity should work with you. Excite them. Ask questions. Try and avoid copy and pasting words from elsewhere.

Once the client has chosen their partner, we'll introduce them over email and keep in touch with both parties to see how it's going. Sometimes things progress quickly. Sometimes because of changing priorities for either party, things progress slowly, but you never know - your next big business break could start right here.

?What value does EEN add?
This is your pitch: remember to include your unique selling points (USP) and why someone would want to do business with you
Tell us why you are a good fit for this opportunity, and why you think you're the right people for this partnership
If there's anything additional, or commercially sensitive you'd like to know about this opportunity, please let us know

When you entered your email address above, we emailed you a code to verify you're human and have access to that account.

?What's this?

What next?

To finish up, we just need some extra details about you and your company